Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/EUCTR2007-007059-14-IT
EUCTR2007-007059-14-ITActive, not recruitingNot Applicable

Role of the Glutatione reduced in the prevention of neuro-toxicity from Oxaliplatino.

AZIENDA DI RILIEVO NAZIONALE E DI ALTA SPECIALIZZAZIONE OSPEDALE CIVICO E BENFRATELLI, G.DI CRISTINA E M.ASCOLI0 sitesStarted: March 5, 2012Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •Patients with istological or cytological diagnosis of neoplasia malignant. Presence of measurable and/or valued disease according to criteria RECIST. Age comprised between 18 and 75 years. Performance status => 60 sec. Karnofsky. Expectation of advanced life to 3 months. Adapted reservoir medullary. Adapted hepatic, renal and cardiac functionality. Informed consent written.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range: 0
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • •Previous chemotherapy with neurotoxic drugs. Presence of cerebral metastases. Carcinomatosa meningitis. Fibrous interstitial. Interstitial pneumonia. Cardiac lack of balance congestizio or strict arrhythmy or recent coronaric ischemica disease. Women in pregnancy or breast-feeding. Patients with infections in active or not controlled phase, or with known infection HIV. Other concomitant pathologies that contraindicate drugs in study to judgment of the clinician. Inability to supply an informed consent. Impossibility to guarantee the follow-up.

Investigators

Sponsor
AZIENDA DI RILIEVO NAZIONALE E DI ALTA SPECIALIZZAZIONE OSPEDALE CIVICO E BENFRATELLI, G.DI CRISTINA E M.ASCOLI

Similar Trials

Completed
Phase 1
se of a substance to prevent and control mouth inflammation caused by radiotherapyStomatitis
RBR-9yrnbgniversidade Estadual da Paraíba
Completed
Phase 4
A new method to reduce the blackish discoloration of the tooth caused during the treatment of early childhood caries.
CTRI/2019/11/022103Manipal College of Dental Sciences Mangalore20
Completed
Not Applicable
The effect of Glutamine Oral gel onprevention of chemotherapy-induced mucositisOral mucositis.Oral mucositis (ulcerative)
IRCT201411153106N19Pharmaceutical science branch of Islamic Azad University50
Recruiting
Phase 3
effect of anti-glaucoma agents on intra ocular pressure Spikes after intravitreal bevacizumab injection in patients
IRCT20230330057787N1Zahedan University of Medical Sciences108
Not yet recruiting
Phase 1
A clinical trial to assess the effectiveness of calcium gluconate in prevention of weakness of uterus during lower segmental cesarean section delivery.
CTRI/2023/07/055182AIIMS New Delhi